Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intrexon Corp (NYSE:XON)

13.34
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
10.26
Today|||52-Week Range
31.38
-44.57%
Year-to-Date

Today’s Trading

Previous close13.34
Today’s open12.37
Day’s range12.34 - 14.09
Volume2,727,351
Average volume (3 months)1,166,046
Market cap$1.6B
Dividend yield--
Data as of 4:02pm ET, 11/22/2017

Growth & Valuation

Earnings growth (last year)-107.89%
Earnings growth (this year)+32.28%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+9.98%
P/E ratioNM
Price/Sales15.02
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...0.000.00%
HALOHalozyme Therapeutic...0.000.00%
AVXSAveXis Inc0.000.00%
ONCESpark Therapeutics I...0.000.00%
Data as of 4:00pm ET, 11/22/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$190.9M
Annual profit (last year)-$186.6M
Net profit margin-97.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Andrew J. Last
Corporate headquarters
Germantown, Maryland

Forecasts